Johnson & Johnson on Friday announced it would acquire heart device firm Shockwave Medical for $13.1 billion. It's J&J's second billion-dollar deal in the cardiovascular space in two years, following its 2022 purchase of Abiomed for $16.6 billion.
You are viewing a robot-friendly page.Click hereto reload in standard format.